Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients that are diagnosed with Bipolar Disorder Type 1 according to diagnostic criteria DSM - IV
Patients that have started therapy with atypical antipsychotics as monotherapy or cotherapy with mood stabilizers the last three months, but have completed 2 full months of therapy.
Patients with anxiety disorder can be recruited in the study unless it is dominant.
You may not be if
Patients that use antidepressant medication
Patients who were treated with depot antipsychotic in the last quarter before their enrollment in the study.
Patients who are addicts of toxic substances.
Patients who suffer from other serious diseases.
Clareo Health | Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers
